FDA says high demand leads to Adderall shortage

COLUMBIA, Mo. (KMIZ)

Some Americans might be finding it hard to get their medications amid a shortage of a popular prescription drug.

The Food and Drug Administration has declared a shortage of the immediate-release formulation of Adderall, which is used to treat conditions including ADHD and narcolepsy. The FDA said in a statement last week that it remains in contact with manufacturers of the drug, keeping up to date about their operations and production. One of the companies, Teva, has been experiencing manufacturing delays, the FDA says.

Teva isn't the only company that produces Adderall. Other companies continue to produce the drug but there is not a sufficient supply to continue to match the demand in the United States.

Although immediate-release Adderall is in shortage there are currently other treatment options available. The extended-release version of Adderall is still available to health care providers and their patients as long as it is deemed appropriate for a patient's needs. And some tablet strengths of

The FDA utilizes a drug shortage webpage that provides more information about drug shortages and is updated regularly.

It wasn't immediately clear if or how severe the shortage is in Mid-Missouri.

Check back for updates to this developing story.